Risultati della ricerca - Hung V.‐T. Nguyen
- Mostra 1 - 4 risultati su 4
-
1
Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity di Jonathan C. Barnes, Peter M. Bruno, Hung V.‐T. Nguyen, Longyan Liao, Jenny Liu, Michael T. Hemann, Jeremiah A. Johnson
Pubblicazione 2016Artigo -
2
Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma di Alexandre Detappe, Hung V.‐T. Nguyen, Yivan Jiang, Michael P. Agius, Wencong Wang, C. Mathieu, Nang Kham Su, Samantha L. Kristufek, David Lundberg, Sachin Bhagchandani, Irene M. Ghobrial, P. Peter Ghoroghchian, Jeremiah A. Johnson
Pubblicazione 2023Artigo -
3
Synthetic Glycomacromolecules of Defined Valency, Absolute Configuration, and Topology Distinguish between Human Lectins di Manuel Hartweg, Yivan Jiang, Gökhan Yilmaz, Cassie M. Jarvis, Hung V.‐T. Nguyen, Gastón A. Primo, Alessandra Monaco, Valentin P. Beyer, Kathleen K. Chen, Somesh Mohapatra, Simon Axelrod, Rafael Gómez‐Bombarelli, Laura L. Kiessling, C. Remzi Becer, Jeremiah A. Johnson
Pubblicazione 2021Artigo -
4
Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation di Sachin Bhagchandani, Farrukh Vohidov, Lauren E. Milling, Yuzhou Evelyn Tong, Christopher M. Brown, Michelle L. Ramseier, Bin Liu, Timothy Fessenden, Hung V.‐T. Nguyen, Gavin R. Kiel, Lori Won, Róbert Langer, Stefani Spranger, Alex K. Shalek, Darrell J. Irvine, Jeremiah A. Johnson
Pubblicazione 2023Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Biochemistry
Chemistry
Medicine
Pharmacology
Prodrug
Biotechnology
Drug
Immune system
In vivo
Internal medicine
Organic chemistry
Agonist
Antigen
Binding selectivity
Binding site
Bortezomib
C-type lectin
Cancer
Chemotherapy
Cisplatin
Colorectal cancer
Combination therapy
Combinatorics
Context (archaeology)
DC-SIGN
Dendritic cell
Drug action
Drug delivery
Epitope